These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16106018)

  • 21. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF.
    Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM
    Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of ErbB2 gene status, mRNA and protein expression.
    D'Incalci M
    Onkologie; 2006 Jun; 29(6):246-7. PubMed ID: 16770085
    [No Abstract]   [Full Text] [Related]  

  • 25. Integrative analysis of the cancer transcriptome.
    Rhodes DR; Chinnaiyan AM
    Nat Genet; 2005 Jun; 37 Suppl():S31-7. PubMed ID: 15920528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer biomarker profiling with microRNAs.
    Jeffrey SS
    Nat Biotechnol; 2008 Apr; 26(4):400-1. PubMed ID: 18392022
    [No Abstract]   [Full Text] [Related]  

  • 27. Microarrays in cancer: research and applications.
    Ochs MF; Godwin AK
    Biotechniques; 2003 Mar; Suppl():4-15. PubMed ID: 12664679
    [No Abstract]   [Full Text] [Related]  

  • 28. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer.
    Serrano-Olvera A; Dueñas-González A; Gallardo-Rincón D; Candelaria M; De la Garza-Salazar J
    Cancer Treat Rev; 2006 May; 32(3):180-90. PubMed ID: 16483720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysing gene expression data from DNA microarrays to identify candidate genes.
    Wu TD
    J Pathol; 2001 Sep; 195(1):53-65. PubMed ID: 11568891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy.
    Parikh RR; Yang Q; Haffty BG
    Cancer; 2007 Feb; 109(3):566-73. PubMed ID: 17183558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular assays to predict prognosis of breast cancer.
    Paik S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
    Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology for stage II colorectal cancer: the jury is still out.
    Cascinu S; Zaniboni A; Scartozzi M; Meriggi F
    J Clin Oncol; 2007 Jul; 25(19):2861; author reply 2862-3. PubMed ID: 17602095
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical validation of a customized multiple signature microarray for breast cancer.
    Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
    Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk loci, biological candidates and biomarkers.
    Nat Genet; 2008 Mar; 40(3):257. PubMed ID: 18305468
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.